Pancreatic cancer is one of the most deadly cancers, with a 13% survival rate at five years. But the ability of scientists to custom-design therapeutic vaccines using mRNA technology may change that.
Pancreatic cancer is one of the most deadly cancers, with a 13% survival rate at five years. But the ability of scientists to custom-design therapeutic vaccines using mRNA technology may change that.